» Articles » PMID: 35247384

Methyltransferase METTL8 is Required for 3-methylcytosine Modification in Human Mitochondrial TRNAs

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2022 Mar 5
PMID 35247384
Authors
Affiliations
Soon will be listed here.
Abstract

A subset of eukaryotic tRNAs is methylated in the anticodon loop, forming 3-methylcytosine (mC) modifications. In mammals, the number of tRNAs containing mC modifications has been expanded to include mitochondrial (mt) tRNA-Ser-UGA and mt-tRNA-Thr-UGU. However, whereas the enzymes catalyzing mC formation in nuclear-encoded tRNAs have been identified, the proteins responsible for mC modification in mt-tRNAs are unknown. Here, we show that mC formation in human mt-tRNAs is dependent upon the methyltransferase-Like 8 (METTL8) enzyme. We find that METTL8 is a mitochondria-associated protein that interacts with mitochondrial seryl-tRNA synthetase, as well as with mt-tRNAs containing mC. We demonstrate that human cells deficient in METTL8 exhibit loss of mC modification in mt-tRNAs, but not nuclear-encoded tRNAs. Consistent with the mitochondrial import of METTL8, the formation of mC in METTL8-deficient cells could be rescued by re-expression of WT METTL8, but not by a METTL8 variant lacking the N-terminal mitochondrial localization signal. Notably, we found METTL8-deficiency in human cells causes alterations in the native migration pattern of mt-tRNA-Ser-UGA, suggesting a role for mC in tRNA folding. Altogether, these findings demonstrate that METTL8 is required for mC formation in mt-tRNAs and uncover a potential function for mC modification in mitochondrial tRNA structure.

Citing Articles

Transcriptome-wide mapping of N3-methylcytidine modification at single-base resolution.

Gao Y, Hou J, Wei S, Wu C, Yan S, Sheng J Nucleic Acids Res. 2025; 53(5).

PMID: 40071931 PMC: 11897884. DOI: 10.1093/nar/gkaf153.


Epileptic encephalopathy linked to a DALRD3 missense variant that impairs tRNA modification.

Zhang K, Lohner K, Lemmink H, Boon M, Lentini J, de Silva N HGG Adv. 2024; 6(1):100377.

PMID: 39482881 PMC: 11615593. DOI: 10.1016/j.xhgg.2024.100377.


tRNA and tsRNA: From Heterogeneity to Multifaceted Regulators.

Li Y, Yu Z, Jiang W, Lyu X, Guo A, Sun X Biomolecules. 2024; 14(10).

PMID: 39456272 PMC: 11506809. DOI: 10.3390/biom14101340.


mC32 tRNA modification controls serine codon-biased mRNA translation, cell cycle, and DNA-damage response.

Cui J, Sendinc E, Liu Q, Kim S, Fang J, Gregory R Nat Commun. 2024; 15(1):5775.

PMID: 38982125 PMC: 11233606. DOI: 10.1038/s41467-024-50161-y.


Methylation modifications in tRNA and associated disorders: Current research and potential therapeutic targets.

Wu Z, Zhou R, Li B, Cao M, Wang W, Li X Cell Prolif. 2024; 57(9):e13692.

PMID: 38943267 PMC: 11503269. DOI: 10.1111/cpr.13692.